Yes, although this Senate hearing was heavy on HCQ
Post# of 148185
(Total Views: 636)
Posted On: 11/19/2020 3:08:05 PM
Yes, although this Senate hearing was heavy on HCQ, there were many positives for leronlomab.
1. Education on the virulogic vs immunologic phase
2. Emphasis on more approval of therapeutics
3. Outpatient (m/m) population is becoming a crowded space. Leronlimab is standing alone (or in the lead spot) in s/c.
1. Education on the virulogic vs immunologic phase
2. Emphasis on more approval of therapeutics
3. Outpatient (m/m) population is becoming a crowded space. Leronlimab is standing alone (or in the lead spot) in s/c.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼